Physician

Gabriel Vidal, M.D.

According to 2025 Medicare claims, Gabriel Vidal, M.D. (NPI: 1487032116) practices radiation oncology in the Lawton, OK market, with the plurality of this provider's patient population coming from Comanche, OK. This provider's primary affiliated billing organization is CANCER CENTERS OF SOUTHWEST OKLAHOMA, LLC (NPI: 1073787792; TIN: 203315309) and primary practice location at 73505-6100.

Vidal's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 432 traditional Medicare patients, billed 3,538 HCPCS/CPT codes, and received $262,151 in Medicare payments. The top billing code was 77427 (Radiation treatment management, 5 treatment sessions). Part D data shows 167 prescription claims across 78 beneficiaries totaling $3,356 in drug costs, led by Ssd (Silver Sulfadiazine). Open Payments data shows 12 records totaling $28,469. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $6,135 to $262,151. In contrast, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $25,016 to $3,356. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$131K$262K2019 Medicare payment: $6,135 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $21,846 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $12,444 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,050 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $126,292 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $262,151 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
201932102$6,135
202094355$21,846
202166194$12,444
20221114$1,050
20232331,661$126,292
20244323,538$262,151

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$13K$25K2016 Drug cost: $25,016 (USD; Tot_Drug_Cst)2017 Drug cost: $18,403 (USD; Tot_Drug_Cst)2018 Drug cost: $24,478 (USD; Tot_Drug_Cst)2019 Drug cost: $1,555 (USD; Tot_Drug_Cst)2020 Drug cost: $941 (USD; Tot_Drug_Cst)2021 Drug cost: $458 (USD; Tot_Drug_Cst)2023 Drug cost: $782 (USD; Tot_Drug_Cst)2024 Drug cost: $3,356 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
20161179$25,016
201728103$18,403
201822105$24,478
20192139$1,555
20201132$941
20211731$458
2022N/RN/RN/R
20233461$782
202478167$3,356

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
77427Radiation treatment management, 5 treatment sessions165545$139
99205New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more133133$128
77334Design and construction of complex radiation treatment device144422$44
77014Ct guidance for insertion of radiation therapy fields161723$33
77300Calculation of radiation therapy dose158508$24

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
SsdSilver Sulfadiazine30620$589
Silver SulfadiazineSilver Sulfadiazine14349$156
Pantoprazole SodiumPantoprazole Sodium19750$120

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$27Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.11$28,442MicroVention, Inc.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Gabriel Vidal, M.D.?

Tedicare shows public-source Medicare data for Gabriel Vidal, M.D. (NPI 1487032116), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Gabriel Vidal, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Gabriel Vidal, M.D.?

Gabriel Vidal, M.D. is linked to CANCER CENTERS OF SOUTHWEST OKLAHOMA, LLC (billing NPI 1073787792) in the available physician profile data.

Does Gabriel Vidal, M.D. have Open Payments data?

Gabriel Vidal, M.D. has 12 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.